<DOC>
	<DOCNO>NCT01527773</DOCNO>
	<brief_summary>TOPDOCS prospective cohort study include COPD patient currently six study center Switzerland . Patients COPD GOLD stag I-IV enrol followed-up annually least 3 year . Yearly assessment include detailed patient history , quality life activity questionnaire , history exacerbation , lung function , measurement exercise capacity , measurement vascular function , exhale breath analysis blood sampling . The overall objective project establish meticulously characterized cohort COPD patient live Switzerland order allow high quality research pathogenesis , treatment complication COPD . The specific aim project determine clinically relevant COPD phenotypes biological factor influence vascular function COPD patient .</brief_summary>
	<brief_title>Phenotypes Vascular Damage Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion : Proven COPD ( GOLD stag IIV ) Age : 4075 year Exclusion criterion : Mental physical disability precluding inform consent compliance protocol Acute recent ( within last 6 week ) exacerbation COPD</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>COPD</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Phenotypes</keyword>
</DOC>